Evidence map›Paper›PMID 28797737›Full record

ArticleTransplant immunology2017

NKT cells are important mediators of hepatic ischemia-reperfusion injury.

James A Richards, Stephen J Wigmore, Stephen M Anderton, Sarah E M Howie

Abstract read
In one paragraph

Article in Transplant immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Immune response associated with ischemia and reperfusion injury during organ transplantation.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2022
    Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

James A RichardsMRC Centre for Inflammation Research, The University of Edinburgh, Edinburgh, UK; Clinical Surgery, The University of Edinburgh, Edinburgh, UK. Electronic address: jamesrichards@doctors.net.uk.
Stephen J WigmoreMRC Centre for Inflammation Research, The University of Edinburgh, Edinburgh, UK; Clinical Surgery, The University of Edinburgh, Edinburgh, UK.
Stephen M AndertonMRC Centre for Inflammation Research, The University of Edinburgh, Edinburgh, UK.
Sarah E M HowieMRC Centre for Inflammation Research, The University of Edinburgh, Edinburgh, UK.

Funding

Medical Research Council G0801924Wellcome Trust WT 092494/Z/10/Z
6 · The paper itself

Abstract

introductionIRI results from the interruption then reinstatement of an organ's blood supply, and this poses a significant problem in liver transplantation and resectional surgery. In this paper, we explore the role T cells play in the pathogenesis of this injury. MATERIALS &

methodsWe used an in vivo murine model of warm partial hepatic IRI, genetically-modified mice, in vivo antibody depletion, adoptive cell transfer and flow cytometry to determine which lymphocyte subsets contribute to pathology. Injury was assessed by measuring serum alanine aminotransfersase (ALT) and by histological examination of liver tissue sections.

resultsThe absence of T cells (CD3εKO) is associated with significant protection from injury (p=0.010). Through a strategy of antibody depletion it appears that NKT cells (p=0.0025), rather than conventional T (CD4+ or CD8+) (p=0.11) cells that are the key mediators of injury. DISCUSSION: Our results indicate that tissue-resident NKT cells, but not other lymphocyte populations are responsible for the injury in hepatic IRI. Targeting the activation of NKT cells and/or their effector apparatus would be a novel approach in protecting the liver during transplantation and resection surgery; this may allow us to expand our current criteria for surgery.

Indexed as

Liver TransplantationAnimalsCD3 ComplexHomeodomain ProteinsHumansLiverLymphocyte DepletionMaleMiceMice, Inbred C57BLMice, KnockoutMice, TransgenicNatural Killer T-CellsReperfusion InjuryT-LymphocytesCD3 ComplexHomeodomain ProteinsRAG-1 proteinAcute liver injuryIschemia-reperfusion injury (IRI)Liver surgeryNatural killer cellsNKT cellsT cellsTransplantation

Identifiers

PMID28797737
PMCPMC5694034

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.